Related Experiment Video
Updated: May 25, 2026

12:00
Preparation and Characterization of SDF-1α-Chitosan-Dextran Sulfate Nanoparticles
Published on: January 22, 2015
Chitosan nanoparticles: a survey of preparation methods
1CBME-Centre for Molecular and Structural Biomedicine, IBB-Institute for Biotechnology and Bioengineering, University of Algarve, Campus de Gambelas, Faro, Portugal. amgrenha@ualg.pt
Journal of Drug Targeting
|February 3, 2012
Summary
Chitosan nanoparticles offer a promising solution for delivering therapeutic macromolecules, overcoming stability and permeation challenges. This review details various chitosan nanocarrier production methods and influencing factors.
Area of Science:
- Pharmaceutical Science
- Biomaterials Engineering
Background:
- Macromolecule therapeutics face challenges with stability and permeation.
- Non-injectable drug carriers, particularly nanoparticles, are crucial for overcoming these limitations.
- Nanoparticles offer a high surface-to-volume ratio for enhanced epithelial interaction and payload protection.
Purpose of the Study:
- To provide a comprehensive overview of methods for producing chitosan nanocarriers.
- To detail the variables affecting the properties of chitosan-based nanocarriers.
- To highlight chitosan's potential as a versatile excipient for drug delivery vehicles.
Main Methods:
- Review of existing literature on chitosan nanoparticle synthesis.
- Categorization of production methods based on hydrophilic and lipophilic environments.
- Analysis of factors influencing nanocarrier characteristics.
Main Results:
- Chitosan is a prominent material for nanocarrier formulation.
- Diverse methods exist for chitosan nanoparticle production, varying in conditions (mild to aggressive).
- Specific variables significantly impact the final properties of chitosan nanocarriers.
Conclusions:
- Chitosan nanocarriers are effective in addressing macromolecule delivery issues.
- Understanding production variables is key to optimizing nanocarrier performance.
- Further research into chitosan-based drug delivery systems is warranted.

